Feedback receives funding for cloud-based tuberculosis programme
pharmafile | December 13, 2021 | News story | Sales and Marketing |
Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based tuberculosis (TB) screening services to rural communities in India.
The technology will enable a chest X-ray image to be sent over a mobile network to the cloud, where it is shared by Bleepa either with a specialist clinician for reporting or a suitable AI tool. The results are then shared through Bleepa with the TB screening services.
Feedback has been awarded funding through the AWS Diagnostic Development Initiative, to deliver a revolutionary imaging pathway to enable X-rays of patients to be acquired without networked connectivity, and be transmitted over Bleepa’s cloud-hosted infrastructure for reporting. This pathway will enable TB screening to be undertaken in remote settings, ensuring diagnostic input is made available to screening services whilst the patient is still in the X-ray clinic.
The AWS Diagnostics Development Initiative is focused on advancing researching and innovation, to improve the collective understanding and detection of infectious diseases, in order to mitigate current and future outbreaks.
There are approximately 2.6 million new TB cases in India every year. It is therefore essential to develop a screening programme for local citizens, to identify those affected and initiate treatment for the condition.
Dr Tom Oakley, CEO of Feedback, said: “We are delighted to have AWS as a partner in our TB screening programme. This funding support will enable us to establish and subsequently scale the TB screening solution to citizens in rural locations across India. It is a key public health priority and a challenge of enormous proportions. To have AWS support and backing will make all the difference in getting this out to the citizens who need it.”
“Cloud-powered diagnostic tools are critical in the fight against turberculosis and other infectious diseases,” said Maggie Carter, Global Lead, Social Impact at AWS. “Over the last year, AWS has seen inspirational results from the Diagnostic Development Initiative. We look forward to helping Bleepa and other organisations worldwide use the cloud to mitigate current and future infectious disease outbreaks.”
Lina Adams
